U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Criminal Investigations
  4. Press Releases
  5. California Man Sentenced for Selling Unapproved Drugs with Intent to Defraud over the Internet
  1. Press Releases

California Man Sentenced for Selling Unapproved Drugs with Intent to Defraud over the Internet

OCI badge

Burlington, Vermont – The Office of the United States Attorney for the District of Vermont announced that on February 3, 2025, Jeremy Brown, 55, of Simi Valley, California, was sentenced for introducing into interstate commerce new drugs not approved by the Food and Drug Administration (“FDA”) with the intent to defraud or mislead. The Honorable Christina Reiss, Chief United States District Judge, sentenced the defendant to one year of supervised release and ordered the defendant to pay $100,000 in forfeiture.

According to court records, between March 2019 and December 2023, Brown operated a company, Warrior Labz SARMs, and accompanying websites through which he sold unapproved versions of prescription drugs and other substances. Specifically, Brown sold Selective Androgen Receptor Modulators (“SARMs”), which are substances similar to anabolic steroids; unapproved versions of erectile-dysfunction drugs Viagra and Cialis; and unapproved versions of weight-loss drugs Ozempic, Wegovy, and Rybelsus.

Brown falsely claimed on his websites that the drugs offered for sale were for “research purposes only” and “not for human consumption.” Alongside those claims, however, were claims that the drugs would provide various benefits affecting the structure and function of the human body.

Brown obtained the bulk of the drugs he sold from China. Brown did not verify shipping or storage conditions, nor did he use a lab to verify the contents of the drugs he received from China. But he falsely claimed on his websites that his company used only the highest quality pharmaceutical grade ingredients and U.S. manufacturing practices.

After receiving a warning letter from the FDA in June 2023, Brown continued to sell unapproved drugs over the internet. Between August and December 2023, Brown made three sales of unapproved drugs to an undercover law enforcement account in Vermont.

Acting United States Attorney Michael P. Drescher commended the investigatory efforts of the Food and Drug Administration and the United States Postal Inspection Service.

The prosecutor is Assistant United States Attorney Corinne Smith. Brown is represented by Rick Collins, Esq. and Lisa Shelkrot, Esq. 

Back to Top